New Amsterdam Pharma
Sanjay Keshav possesses extensive experience in the pharmaceutical and biotechnology sectors, having held key leadership positions such as Vice President of Analytics and Insights at NewAmsterdam Pharma and Vice President of Commercial Operations, Analytics and Insights, and Business Development at Biohaven. Previous roles include Head of Marketing for the GI Franchise and Head of Operations and Analytics & Insights at Takeda, as well as Head of Marketing at Omeros Corporation. In addition, Sanjay Keshav served as Senior Director of Marketing - Franchise Lead for Respiratory & CNS at Mylan Pharmaceuticals. Sanjay Keshav's educational background includes an MBA in Marketing from NYU Stern School of Business and a BSIM in Industrial Management from Purdue University.
This person is not in any offices
New Amsterdam Pharma
1 followers
Founded in 2019 by the venture capital firm Forbion and John Kastelein, NewAmsterdam Pharma is a privately held, clinical-stage company focused on the research and development of transformative therapies for cardiometabolic diseases. Its mission is to improve patient care in populations where traditional therapies are not tolerated or have been unsuccessful.